Key facts
- Made Scientific selected as manufacturer for Columbia University's NOVAKnee program.
- NOVAKnee is a first-in-class living biologic total knee replacement.
- The program involves autologous and allogeneic cell therapy implants.
- The initiative is funded by ARPA-H and aims for a Phase I clinical trial.
- The trial will be conducted under FDA oversight.
This development marks a significant step in regenerative medicine for orthopedic treatments. The NOVAKnee program aims to create living biologic implants using stem cell therapy, potentially offering a new approach to total knee replacement. Made Scientific's role as a contract manufacturer is crucial for advancing this innovative therapy towards clinical trials.